White House Says It Will Meet Vaccine Goals Despite Pause In Johnson & Johnson Use

The Center for Disease Control and Prevention and the Food and Drug Administration recommended pausing the use of the Johnson & Johnson vaccine after six rare cases of blood clotting. The White House is emphasizing the condition is extremely uncommon, and it still plans to meet its goal of 200 million doses in President Biden's first 100 days in office. This episode: White House correspondent Scott Detrow, White House correspondent Tamara Keith, and health reporter Selena Simmons-Duffin. Connect: Subscribe to the NPR Politics Podcast here.